In vitro susceptibility testing of meticillin-resistant and meticillin-susceptible staphylococci to mupirocin and novobiocin

Veterinary Dermatology

Volumn 22, Issue 1, 2011, Pages 88-94

  Fulham, Kristen S ^a   Lemarie, Stephen L ^a   Hosgood, Giselle ^b   Dick, Hani L N ^c  

^a Southeast Veterinary Specialists ^*  (United States)

^b MURDOCH UNIVERSITY   (Australia)

^c Department of Microbiology   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; METICILLIN; NOVOBIOCIN; PSEUDOMONIC ACID;

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; DRUG EFFECT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; PENICILLIN RESISTANCE; STAPHYLOCOCCAL SKIN INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; DOG DISEASES; DOGS; METHICILLIN; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MUPIROCIN; NOVOBIOCIN; STAPHYLOCOCCAL SKIN INFECTIONS;

BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; STAPHYLOCOCCUS;

EID: 78651431980     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2010.00921.x     Document Type: Article

References (45)

1. Weese S. Methicillin-resistant Staphylococcus aureus: an emerging pathogen in small animals. Journal of the American Animal Hospital Association 2005; 41: 150-7.
2. Scott DW, Miller WH, Griffen CE. Muller and Kirk's Small Animal Dermatology, 6th edn. Philadelphia, PA: W.B. Saunders, 2001: 274-7.
3. Hajek V. Staphylococcus intermedius, a new species isolated from animals. International Journal of Systemic Bacteriology 1976; 26: 401-8.
4. Bannoehr J, Franco A, Iurescia M et al. Molecular diagnostic identification of Staphylococcus pseudintermedius. Journal of Clinical Microbiology 2009; 47: 469-71.
5. Bannoehr J, Ben Zakour NL, Waller AS et al. Population genetic structure of the Staphylococcus intermedius group: insights into agr diversification and the emergence of methicillin-resistant strains. Journal of Bacteriology 2007; 189: 8685-92.
6. Devriese LA, Hermans K, Beale M et al. Staphylococcus pseudintermedius versus Staphylococcus intermedius. Veterinary Microbiology 2008; 133: 206-7.
7. Sasaki T, Kikuchi K, Tanaka Y et al. Reclassification of phenotypically identified Staphylococcus intermedius strains. Journal of Clinical Microbiology 2007; 45: 2770-8.
8. Weese SJ, van Duijkeren E. Methicillin-resistant Staphylococcus aureus and Staphylococcus pseudintermedius in veterinary medicine. Veterinary Microbiology 2010; 140: 418-29.
9. Zapun A, Contreras-Martel C, Vernet T. Penicillin-binding proteins and β-lactam resistance. FEMS Microbiology Reviews 2008; 32: 361-85.
10. Navratna V, Nadig S, Sood V et al. Molecular basis for the role of Staphylococcus aureus penicillin binding protein 4 in antimicrobial resistance. Journal of Bacteriology 2010; 192: 134-44.
11. Murphy JT, Walshe R, Devocelle M. A computational model of antibiotic-resistance mechanisms in methicillin-resistant Staphylococcus aureus. Journal of Theoretical Biology 2008; 254: 284-93.
12. Ayliffe GA. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clinical Infectious Diseases 1997; 24: S74-9.
13. ®), Freedom of Information. Bristol, TN: Beecham Laboratories, 1998: 1-20.
14. Werner AH, Russell DA. Mupirocin, fusidic acid and bacitracin: activity, action and clinical uses of three topical antibiotics. Veterinary Dermatology 1999; 10: 225-40.
15. Loeffler A, Baines SJ, Toleman MS. In vitro activity of fusidic acid and mupirocin against coagulase-positive staphylococci from pets. Journal of Antimicrobial Chemotherapy 2008; 62: 1301-4.
16. Coates T, Bax R, Coates A. Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects. Journal of Antimicrobial Chemotherapy 2009; 64: 9-15.
17. ® (mupirocin). Proceedings of an International Symposium. Amsterdam: Elsevier, 1985. pp. 47-53.
18. French P, Venuti E, Fraimow HS. In vitro activity of novobiocin against multiresistant strains of Enterococcus faecium. Antimicrobial Agents and Chemotherapy 1993; 37: 2736-9.
19. Plumb DC. Plumb's Veterinary Drug Handbook, 5th edn. Stockholm: Pharma Vet Inc., 2005: 567-8.
20. Finland M, Nichols RL. Current therapeutics. The Practitioner 1957; 179: 84-93.
21. Anderle C, Stieger M, Burrell M et al. Biological activities of novel gyrase inhibitors of the aminocoumarin class. Antimicrobial Agents and Chemotherapy 2008; 52: 1982-90.
22. Kahn C, Line S. The Merck Veterinary Manual, 9th edn. Metairie, LA: Merck & Company, Inc, 2005: 694-6.
23. Fuchs PC, Jones RN, Barry AL. Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic. Journal of Clinical Microbiology 1990; 28: 608-9.
24. Finlay JE, Miller LA, Poupard JA. Interpretive criteria of testing of susceptibility of staphylococci to mupirocin. Antimicrobial Agents and Chemotherapy 1997; 41: 1137-9.
25. Oliveira NEM, Cardozo APCM, Marques EAM et al. Interpretive criteria to differentiate low- and high-level mupirocin resistance in Staphylococcus aureus. Journal of Medical Microbiology 2007; 56: 937-9.
26. Malaviolle X, Nonhoff C, Denis O et al. Evaluation of disc diffusion methods and Vitek 2 automated system for testing susceptibility to mupirocin in Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 2008; 62: 1018-23.
27. Abraham JL, Morris DO, Griffeth GC et al. Surveillance of healthy cats and cats with inflammatory skin disease for colonization of the skin by methicillin-resistant coagulase-positive staphylococci and Staphylococcus schleiferi ssp. schleiferi. Veterinary Dermatology 2007; 18: 252-8.
28. Guardabassi L, Schwarz S, Lloyd DH. Pet animals as reservoirs of antimicrobial-resistant bacteria. Journal of Antimicrobial Chemotherapy 2004; 54: 321-32.
29. O'Mahony R, Abbot Y, Leonard FC et al. Methicillin-resistant Staphylococcus aureus (MRSA) isolated from animals and veterinary personnel in Ireland. Veterinary Microbiology 2005; 109: 285-96.
30. Hanselmann BA, Kruth S, Weese S. Methicillin-resistant staphylococcal colonization in dogs entering a veterinary teaching hospital. Veterinary Microbiology 2008; 126: 277-81.
31. Baptiste KE, Williams K, Williams NJ et al. Methicillin-resistant staphylococci in companion animals. Emerging Infectious Diseases 2005; 11: 1942-4.
32. Bagcigil FA, Moodley A, Baptiste KE et al. Occurrence, species distribution, antimicrobial resistance and clonality of methicillin- and erythromycin-resistant staphylococci in the nasal cavity of domestic animals. Veterinary Microbiology 2007; 121: 307-15.
33. Wu SW, de Lancastre H, Tomasz A. Recruitment of the mecA gene homologue of Staphylococcus sciuri into a resistance determinant and expression of the resistant phenotype in Staphylococcus aureus. Journal of Bacteriology 2001; 183: 2417-24.
34. Bocher S, Tonning B, Skov RL et al. Staphylococcus lugdunensis, a common cause of skin and soft tissue infections in the community. Journal of Clinical Microbiology 2009; 47: 946-50.
35. Jones RM, Jackson MA, Ong C et al. Endocarditis caused by Staphylococcus lugdunensis. The Pediatric Infectious Disease Journal 2002; 21: 265-8.
36. Patel R, Piper KE, Rouse MS et al. Frequency of isolation of Staphylococcus lugdunensis among staphylococcal isolates causing endocarditis: a 20-year experience. Journal of Clinical Microbiology 2000; 38: 4262-3.
37. Schonheyder HC, Hansen VK, Asschenfeldt P et al. Staphylococcus lugdunensis: an important cause of endocarditis, a case report. Acta Pathologica, Microbiologica et Immunologica Scandinavica 1993; 101: 802-4.
38. Bellamy R, Barkham T. Staphylococcus lugdunensis infection sites: predominance of abscesses in the pelvic girdle region. Clinics of Infectious Diseases 2002; 35: E32-4.
39. Van der Mee-Marquet N, Achard NA, Mereghetti L et al. Staphylococcus lugdunensis infections: high frequency of inguinal area carriage. Journal of Clinical Microbiology 2003; 41: 1404-9.
40. Herchline TE, Ayers LW. Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection. Journal of Clinical Microbiology 1991; 29: 419-21.
41. Lina B, Vandenesch F, Reverdy ME. Non-puerperal breast infections due to Staphylococcus lugdunensis. European Journal of Clinical Microbiology and Infectious Diseases 1994; 13: 686-7.
42. Rich M, Deighton L, Roberts L. Clindamycin-resistance in methicillin-resistant Staphylococcus aureus isolated from animals. Veterinary Microbiology 2005; 111: 237-40.
43. Cookson BD. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. Journal of Antimicrobial Chemotherapy 1998; 41: 11-8.
44. Flatman RH, Eustaquio A, Li SM et al. Structure-activity relationships of aminocoumarin-type gyrase and topoisomerase IV inhibitors obtained by combinational biosynthesis. Antimicrobial Agents and Chemotherapy 2006; 50: 1136-42.
45. Walsh TJ, Hansen SL, Tatem BA. Activity of novobiocin against methicillin-resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 1985; 15: 435-40.